ArticleFrontiers in nutrition2025
Association of HbA1c/HDL-C ratio and depression with cardiometabolic multimorbidity in middle-aged and older adults: a nationwide prospective cohort study.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A Cross-Nationally Validated Nomogram for Cardiometabolic Multimorbidity in Overweight/Obese Older Adults: CHARLS and HRS Cohorts.Diabetes, obesity & metabolism · 2026Article
- Glycemic Markers and Cardiometabolic Multiple Long-Term Conditions: Comparative Roles of Glycated Hemoglobin and Fasting Plasma Glucose in the English Longitudinal Study of Ageing.Mayo Clinic proceedings. Innovations, quality & outcomes · 2026Article
- Data-driven glycolipid network phenotypes reveal a graded risk spectrum for cardiometabolic multimorbidity: a prospective study in middle-aged and older Chinese adults.Lipids in health and disease · 2026Article
- Association between glycometabolic indicators and risk of early vascular aging and their predictive value.Frontiers in endocrinology · 2026Article
- The association between HbA1c/HDL-C ratio and cardiometabolic multimorbidity among middle-aged and older adults: data from two national prospective cohorts in the United Kingdom and United States.Frontiers in nutrition · 2026Article
- Nonlinear association of HbA1c/HDL-C ratio with heart failure in adults: a large cross-sectional study.Frontiers in cardiovascular medicine · 2026Article
- Identification of key metabolic indicators associated with the comorbidity of ischemic stroke and diabetes mellitus using an optimal interpretable clinlabomics model.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiometabolic multimorbidity (CMM)-the coexistence of two or more cardiometabolic diseases such as diabetes, heart disease, and stroke-poses serious health risks. Depression has recently been recognized as an independent risk factor for CMM. However, the role of the glycosylated hemoglobin A1c to high-density lipoprotein cholesterol ratio (HbA1c/HDL-C) in predicting CMM remains unclear. This study investigates the independent and combined effects of the HbA1c/HDL-C ratio and depression on CMM risk in middle-aged and older adults. Methods: Data were drawn from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018, including 7,256 participants aged 45 and above. Kaplan-Meier analysis estimated cumulative CMM incidence. Multivariable Cox proportional hazards models assessed the independent and joint effects of the HbA1c/HDL-C ratio and depression on CMM risk. Restricted cubic splines evaluated potential nonlinear relationships. Receiver operating characteristic (ROC) analysis compared the predictive performance of the HbA1c/HDL-C ratio, depression, and their combination. Subgroup and sensitivity analyses tested the robustness of findings. Results: Over the 7-year follow-up, 419 participants (5.77%) developed CMM. Higher HbA1c/HDL-C ratios and depression were associated with greater cumulative incidence of CMM. The HbA1c/HDL-C ratio was positively associated with CMM risk, showing a nonlinear trend. Participants with both a high HbA1c/HDL-C ratio and depression had significantly increased CMM risk (HR = 2.59, 95% CI: 1.82-3.68) compared to those with either factor alone. Combined analysis consistently outperformed single predictors in ROC analysis. Subgroup and sensitivity analyses confirmed the robustness of results. Depression did not mediate the HbA1c/HDL-C-CMM association. Conclusion: Both the HbA1c/HDL-C ratio and depression are independently associated with CMM. Depression did not mediate the association between the HbA1c/HDL-C ratio and CMM. Their combined effect substantially increases CMM risk, underscoring the importance of integrating metabolic and psychological assessments in early identification and personalized prevention strategies for high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.